Study spanning 2 decades offers insights into pediatric psoriasis trendsJuly 8, 2021PediatricsPsoriatic Arthritis
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitisJuly 1, 2021Psoriatic ArthritisMixed TopicsAnkylosing spondylitisSpondyloarthropathies
Biologic treatment mitigates PsA risk in psoriasis patients, study findsJune 24, 2021Psoriatic Arthritis
Secukinumab provides clinical benefit in phase 3 juvenile arthritis trialJune 15, 2021PediatricsPsoriatic Arthritis
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseasesMay 25, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Multiple studies highlight pandemic’s impact on patients with rheumatic diseaseMay 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Psoriasis associated with an increased risk of COVID-19 in real-world studyApril 28, 2021COVID-19 UpdatesPsoriatic Arthritis
Boosting the presence of darker skin in rheumatology educationApril 21, 2021Diversity in MedicineLupus & Connective Tissue DiseasesPsoriatic ArthritisPediatricsRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccinationApril 20, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Rheumatology clinics find success with smoking cessation referral programApril 8, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
